Cited by 4,945Health Promotion and Cardiovascular PreventionCoronary Interventions and DiagnosticsClinical practice guidelines implementation

The DOI matches its Crossref record, with a small difference in title or year; 86 of the 87 references it cites were found in a registry or an index.

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Open access

Goff, David C., Lloyd-Jones, Donald M., Bennett, Glen, Coady, Sean, D’Agostino, Ralph B., Gibbons, Raymond, Greenland, Philip, Lackland, Daniel T., Levy, Daniel, O’Donnell, Christopher J., Robinson, Jennifer G., Schwartz, J. Sanford, Shero, Susan T., Smith, Sidney C., Sorlie, Paul, Stone, Neil J., Wilson, Peter W.F.·2014·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2013.11.005PMC PMC4700825

Open this paper in CoChat — free account

Abstract

Harmon S. Jordan, ScD, Lev Nevo, MD, Janusz Wnek, PhD Jeffrey L. Anderson, MD, FACC, FAHA, Chair , Jonathan L. Halperin, MD, FACC, FAHA, Chair-Elect , Nancy M. Albert, PhD, CCNS, CCRN, FAHA, Biykem Bozkurt, MD, PhD, FACC, FAHA, Ralph G. Brindis, MD, MPH, MACC, Lesley H. Curtis, PhD, FAHA, David

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2013.11.005

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Self-citation
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Self-citation
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Self-citation
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Self-citation

Show all 87 references

Sorted by citations

Items 1,001–1,030 of 1,030

Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial
Rahman, F., McEvoy, J. W., Ohkuma, T., Marre, M., Hamet, P., Harrap, S., Mancia, G., Rodgers, A., Selvin, E., Williams, B., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12414 · Cited by 48
Development of a Risk Equation for the Incidence of Coronary Artery Disease and Ischemic Stroke for Middle-Aged Japanese – Japan Public Health Center-Based Prospective Study –
Yatsuya, H., Iso, H., Li, Y., Yamagishi, K., Kokubo, Y., Saito, I., Sawada, N., Inoue, M., & Tsugane, S. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0081 · Cited by 47
Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction
Naghavi, M., Reeves, A. P., Atlas, K., Zhang, C., Atlas, T., Henschke, C. I., Yankelevitz, D. F., Budoff, M. J., Li, D., Roy, S. K., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01308-0 · Cited by 45
Self-citation
Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study
Lin, H.-Q., Wu, J.-Y., Chen, M.-L., Chen, F.-Q., Liao, Y.-J., Wu, Y.-T., & Guo, Z.-J. (2019) · Clinical Interventions in Aging · doi:10.2147/cia.s207665 · Cited by 44
Comparison of the cardiovascular benefits of resistance, aerobic, and combined exercise (CardioRACE): rationale, design, and methods
Brellenthin, A. G., Lanningham-Foster, L. M., Kohut, M. L., Li, Y., Church, T. S., Blair, S. N., & Lee, D.-C. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.08.008 · Cited by 43
Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial
Sherwood, A., Blumenthal, J. A., Smith, P. J., Watkins, L. L., Hoffman, B. M., & Hinderliter, A. L. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000301 · Cited by 44
Adverse pregnancy conditions, infertility, and future cardiovascular risk: implications for mother and child
Park, K., Wei, J., Minissian, M., Bairey Merz, C. N., & Pepine, C. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6597-2 · Cited by 40
Comparability of lipoprotein particle number concentrations across ES-DMA, NMR, LC-MS/MS, immunonephelometry, and VAP: in search of a candidate reference measurement procedure for apoB and non-HDL-P standardization
Delatour, V., Clouet-Foraison, N., Gaie-Levrel, F., Marcovina, S. M., Hoofnagle, A. N., Kuklenyik, Z., Caulfield, M. P., Otvos, J. D., Krauss, R. M., Kulkarni, K. R., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.288746 · Cited by 39
Race and Ethnicity: A Part of the Equation for Personalized Clinical Decision Making?
Paulus, J. K., & Kent, D. M. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.117.003823 · Cited by 35
A comparison of three apolipoprotein B methods and their associations with incident coronary heart disease risk over a 12-year follow-up period: the Multi-Ethnic Study of Atherosclerosis
Cao, J., Steffen, B. T., Guan, W., Remaley, A. T., McConnell, J. P., Palamalai, V., & Tsai, M. Y. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.12.013 · Cited by 31
Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling
Clouet-Foraison, N., Gaie-Levrel, F., Gillery, P., & Delatour, V. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0091 · Cited by 30
Healthy diet reduces markers of cardiac injury and inflammation regardless of macronutrients: Results from the OmniHeart trial
Kovell, L. C., Yeung, E. H., Miller, E. R., Appel, L. J., Christenson, R. H., Rebuck, H., Schulman, S. P., & Juraschek, S. P. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.102 · Cited by 27
Associations between Inflammatory Markers and Subclinical Atherosclerosis in Middle-aged White, Japanese-American and Japanese Men: The ERA-JUMP Study
Nagasawa, S.-Y., Ohkubo, T., Masaki, K., Barinas-Mitchell, E., Miura, K., Seto, T., El-Saed, A., Kadowaki, T., Willcox, B. J., Edmundowicz, D., et al. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.23580 · Cited by 26
A randomized controlled trial of gamification, financial incentives, or both to increase physical activity among patients with elevated risk for cardiovascular disease: rationale and design of the be active study
Fanaroff, A. C., Patel, M. S., Chokshi, N., Coratti, S., Farraday, D., Norton, L., Rareshide, C., Zhu, J., Szymczak, J. E., Russell, L. B., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.02.014 · Cited by 23
Effects of Race Are Rarely Included in Clinical Prediction Models for Cardiovascular Disease
Paulus, J. K., Wessler, B. S., Lundquist, C. M., & Kent, D. M. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4475-x · Cited by 22
Cardiovascular biomarkers in clinical studies of type 2 diabetes
Baldassarre, M. P. A., Andersen, A., Consoli, A., Knop, F. K., & Vilsbøll, T. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13247 · Cited by 22
Barriers to technology use among older heart failure individuals in managing their symptoms after hospital discharge
Nguyen, L., Keshavjee, K., Archer, N., Patterson, C., Gwadry-Sridhar, F., & Demers, C. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.06.001 · Cited by 22
Coronary calcification in adults with Turner syndrome
Schoepp, M., Hannah-Shmouni, F., Matta, J., Ghanem, A. M., Hanover, J. A., Abd-Elmoniem, K. Z., & Gharib, A. M. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.149 · Cited by 21
Improving Cardiovascular Disease Prediction With Machine Learning Using Mental Health Data
Dorraki, M., Liao, Z., Abbott, D., Psaltis, P. J., Baker, E., Bidargaddi, N., Wardill, H. R., van den Hengel, A., Narula, J., & Verjans, J. W. (2024) · JACC: Advances · doi:10.1016/j.jacadv.2024.101180 · Cited by 19
Calibration between the Estimated Probability of the Risk Assessment Chart of Japan Atherosclerosis Society and Actual Mortality Using External Population: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN)
Nakai, M., Miyamoto, Y., Higashiyama, A., Murakami, Y., Nishimura, K., Yatsuya, H., Saitoh, S., Sakata, K., Iso, H., Miura, K., et al. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.31286 · Cited by 10
Triglyceride-rich lipoproteins cholesterol, 10-years atherosclerotic cardiovascular disease risk, and risk of myocardial infarction and ischemic stroke
Jia, Y.-P., Wang, J.-M., Lyu, J.-Q., Yang, H.-H., Miao, M.-Y., Wang, X., Wan, Z.-X., Zheng, Y., Qin, L.-Q., Li, F.-R., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100653 · Cited by 10
Predicted Risk, Preclinical Heart Failure Measures, and Incident Heart Failure
Grant, J. K., Zhang, S., Khan, S. S., Ozkan, B., Blumer, V., Nambi, V., Echouffo-Tcheugui, J. B., Pandey, A., Blumenthal, R. S., Ballantyne, C. M., et al. (2025) · JACC: Heart Failure · doi:10.1016/j.jchf.2025.102659 · Cited by 8
Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender
Goyal, A., Cooper, H. A., Aronow, W. S., Nagpal, P., Yandrapalli, S., Nabors, C. C., & Frishman, W. H. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.05.029 · Cited by 6
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?
Abdul Jabbar, A. B., Inam, M., Butt, N., Khan, S. S., Sheikh, S., Khoja, A., Perry, B., Gomez, G. Z., Slipczuk, L., & Virani, S. S. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01320-z · Cited by 7
Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?
Fairman, K. A., Davis, L. E., Peckham, A. M., & Sclar, D. A. (2018) · Drugs - Real World Outcomes · doi:10.1007/s40801-017-0129-2 · Cited by 5
HDL Cholesterol Is Remarkably Cardioprotective Against Coronary Artery Disease in Native Hawaiians and Pacific Islanders
Szatrowski, A., Maggio, Z., & Khomtchouk, B. (2025) · JACC: Advances · doi:10.1016/j.jacadv.2025.101741 · Cited by 4
Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I
Naghavi, M., Azimi, A., Atlas, K., Reeves, A. P., Zhang, C., Mirjalili, S. R., Mozafarybazargany, M., Jolfayi, A. G., Hashemi, A., Atlas, T., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101698 · Cited by 2
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
Douglas, P. S., Hoffmann, U., Patel, M. R., Mark, D. B., Al-Khalidi, H. R., Cavanaugh, B., Cole, J., Dolor, R. J., Fordyce, C. B., Huang, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415516 · Cited by 1,543
Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels?: The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi‐Ethnic Study of Atherosclerosis (MESA)
Liu, K., Colangelo, L. A., Daviglus, M. L., Goff, D. C., Pletcher, M., Schreiner, P. J., Sibley, C. T., Burke, G. L., Post, W. S., Michos, E. D., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002275 · Cited by 128
Self-citation
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117

Authors: Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., Robinson, J. G., Schwartz, J. S., Shero, S. T., Smith, S. C., Sorlie, P., Stone, N. J., & Wilson, P. W. F.
Affiliations: General Department of Preventive Medicine (VN)
ORCID: Goff, David C.
D’Agostino, Ralph B.
Gibbons, Raymond
Greenland, Philip
Lackland, Daniel T.
Levy, Daniel
O’Donnell, Christopher J.
Robinson, Jennifer G.
Shero, Susan T.
Smith, Sidney C.
Stone, Neil J.
Wilson, Peter W.F.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2014-07
Volume: 63
Issue: 25
Pages: 2935-2959
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2013.11.005
PMC: PMC4700825
OpenAlex: W2168536722
Cited by: 4,945
References: 87
Citations by year: 2026: 122 · 2025: 207 · 2024: 294 · 2023: 375 · 2022: 443 · 2021: 504 · 2020: 440 · 2019: 469 · 2018: 474 · 2017: 484 · 2016: 439 · 2015: 391 · 2014: 285
FWCI: 383.50
Type: journal article
Language: en
Update notices: erratum (2014-07-01)
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (Z99 HL999999)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords: cardiovascular risk assessment, cardiovascular risk, risk stratification, risk prediction
MeSH terms: American Heart Association, Blood Pressure, Cardiology, Cardiovascular Diseases, Diet, Humans, Morbidity, Risk Factors, Societies, Medical, Sodium, Dietary, United States, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks